Contract Manufacturing, Biopharmaceutical Production

Growing Opportunities in Outsourced Biopharma APIs

September 28, 2023

Consistent growth in outsourced biomanufacturing points to an evolving industry increasingly reliant on external capacity and expertise.

Samsung Biologics Expands Strategic Manufacturing Agreement with Bristol Myers Squibb

September 20, 2023

Samsung Biologics and Bristol Myers Squibb have further expanded their strategic manufacturing agreement to include the large-scale manufacture of an antibody cancer drug substance.

Three-Way Collaboration Between Rentschler Biopharma, CGT Catapult, and Refeyn Aims to Improve PAT for Gene Therapy Manufacturing

August 29, 2023

Rentschler Biopharma, CGT Catapult, and Refeyn aim to use automated and digital technologies to improve AAV manufacturing for gene therapies.

WuXi XDC, Boostimmune Sign MOU

August 23, 2023

WuXi XDC will provide end-to-end services to support Boostimmune’s discovery of novel bioconjugates.

Staffing Shortages: Major Hurdle for Bioprocess Contract Manufacturing Services in 2023

August 02, 2023

More than a third of CMOs are struggling to keep skilled technical and production staff.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

July 11, 2023

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

WuXi Biologics Expands Manufacturing Capacity in Germany

June 01, 2023

WuXi Biologics is expanding its manufacturing capacity for drug substance and drug product at its sites in Leverkusen and Wuppertal, Germany.

uBriGene Expands into US Market with Acquisition of Mustang Bio's CGT Manufacturing Facility

May 23, 2023

uBriGene Biosciences will acquire Mustang Bio’s Worcester, Mass., CGT manufacturing facility in a deal worth up to $11 million, expanding its operations into the US market.

Synthego Launches New RNA Manufacturing Facility

May 16, 2023

Synthego has opened its new GMP-compliant RNA manufacturing facility in Redwood City, Calif., for CRISPR-enabled genomics therapeutics.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

May 02, 2023

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.